Premium
Structural basis of phosphodiesterase 6 inhibition by the C‐terminal region of the γ‐subunit
Author(s) -
Barren Brandy,
Gakhar Lokesh,
Muradov Hakim,
Boyd Kimberly K,
Ramaswamy S,
Artemyev Nikolai O
Publication year - 2009
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1038/emboj.2009.284
Subject(s) - visual phototransduction , phosphodiesterase , biology , protein subunit , transducin , cgmp specific phosphodiesterase type 5 , binding site , sildenafil , biophysics , plasma protein binding , protein structure , gamma subunit , biochemistry , conformational change , microbiology and biotechnology , retinal , enzyme , anatomy , rhodopsin , gene
The inhibitory interaction of phosphodiesterase‐6 (PDE6) with its γ‐subunit (Pγ) is pivotal in vertebrate phototransduction. Here, crystal structures of a chimaeric PDE5/PDE6 catalytic domain (PDE5/6cd) complexed with sildenafil or 3‐isobutyl‐1‐methylxanthine and the Pγ‐inhibitory peptide Pγ 70−87 have been determined at 2.9 and 3.0 Å, respectively. These structures show the determinants and the mechanism of the PDE6 inhibition by Pγ and suggest the conformational change of Pγ on transducin activation. Two variable H‐ and M‐loops of PDE5/6cd form a distinct interface that contributes to the Pγ‐binding site. This allows the Pγ C‐terminus to fit into the opening of the catalytic pocket, blocking cGMP access to the active site. Our analysis suggests that disruption of the H–M loop interface and Pγ‐binding site is a molecular cause of retinal degeneration in atrd3 mice. Comparison of the two PDE5/6cd structures shows an overlap between the sildenafil and Pγ 70−87 ‐binding sites, thereby providing critical insights into the side effects of PDE5 inhibitors on vision.